Format

Send to

Choose Destination
See comment in PubMed Commons below
Biotechnol Adv. 2009 Jul-Aug;27(4):417-22. doi: 10.1016/j.biotechadv.2009.03.002. Epub 2009 Mar 14.

RNA interference technology to improve recombinant protein production in Chinese hamster ovary cells.

Author information

1
Institute of Biotechnology and Department of Life Science, National Tsing Hua University, Hsinchu 30013, Taiwan. scwu@life.nthu.edu.tw

Abstract

RNA interference (RNAi) technology has become a novel tool for silencing gene expression in cells or organisms, and has also been used to develop new therapeutics for certain diseases. This review describes its other application of using RNAi technology to increase cellular productivity and the quality of recombinant proteins that are produced in Chinese hamster ovary (CHO) cells, the most important mammalian cell line used in producing licensed biopharmaceuticals in these days. The approaches reported include the silencing of apoptosis-associated gene expression, protein glycosylation-associated gene expression, lactate dehydrogenase involved in cellular metabolism, and dihydrofolate reductase used for gene amplification. All of these works belong to the single component approach therefore depends strongly on the identification of the down-regulation of the critical target gene which can markedly influence the cellular functions associated with recombinant protein expression in CHO cells. Future RNAi approaches can be extended to silence multiple targets involved in different cellular pathways for changing the global gene regulation in cells, as well as the targets related to microRNA molecules for cellular self regulation.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center